{"id":7593,"date":"2019-03-12T07:56:45","date_gmt":"2019-03-12T07:56:45","guid":{"rendered":"https:\/\/www.nicox.com\/presentations-nicox-a-de-prochaines-conferences-scientifiques-2\/"},"modified":"2019-03-12T07:56:45","modified_gmt":"2019-03-12T07:56:45","slug":"presentations-nicox-a-de-prochaines-conferences-scientifiques-2","status":"publish","type":"post","link":"https:\/\/www.nicox.com\/fr\/presentations-nicox-a-de-prochaines-conferences-scientifiques-2\/","title":{"rendered":"Pr\u00e9sentations Nicox \u00e0 de prochaines conf\u00e9rences scientifiques"},"content":{"rendered":"<p>Sophia Antipolis, France<\/p>\n<p><strong>Nicox SA<\/strong> (Euronext Paris: FR0013018124, COX, \u00e9ligible PEA-PME), une soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce plusieurs presentations de donn\u00e9es \u00e0 des conf\u00e9rences scientifiques :<\/p>\n<h4><span style=\"text-decoration: underline;\">Informations sur les pr\u00e9sentations (heures locales) :<\/span><\/h4>\n<p><span style=\"text-decoration: underline;\"><strong>AGS 2019 Annual Meeting \u201314-17 mars 2019, San Francisco, Etats-Unis<\/strong><\/span><\/p>\n<p><span style=\"text-decoration: underline;\"><strong>Titre du poster<\/strong> : Preclinical Evaluation of NCX 4251, A Novel Steroid Therapy For Blepharitis, Targeted Directly To The Eyelid Margin To Reduce The Potential For IOP Elevations<\/span><\/p>\n<p><strong>Type<\/strong> : Sessions de posters<\/p>\n<p><strong>Date<\/strong> : 15 mars 2019 de 7:00 \u00e0 17:00<\/p>\n<p><strong>Pr\u00e9sentation<\/strong> : Dr. Robert Fechtner, Directeur du D\u00e9partement d\u2019Ophtalmologie \u00e0 la SUNY Upstate Medical University de Syracuse, New York, Etats-Unis<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>ARVO 2019 Annual Meeting \u2013 28 avril &#8211; 2 mai 2019, Vancouver, Canada\u00a0<\/strong><\/span><em>(SOUS EMBARGO JUSQU&rsquo;AU 30 AVRIL A 22:30 SELON LA POLITIQUE D&rsquo;EMBARGO D&rsquo;ARVO)<\/em><\/p>\n<p><span style=\"text-decoration: underline;\"><strong>Titre du poster<\/strong> : Nonclinical development of NCX 470, a novel nitric oxide (NO)-donating, IOP lowering prostaglandin analog for glaucoma and ocular hypertension<\/span><\/p>\n<p><strong>Type<\/strong> : Sessions de posters<\/p>\n<p><strong>Titre de la session<\/strong> : Pharmacologic Interventions and Cellular Mechanisms<\/p>\n<p><strong>Date<\/strong> : 30 avril 2019 de 11:45 \u00e0 13:30<\/p>\n<p><strong>Pr\u00e9sentation<\/strong> : Elena Bastia, PhD, Institut de recherche de Nicox<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>Titre du poster<\/strong> : Concomitant dosing of the NO-donor NCX 667 (1%) and Xalatan\u00ae (latanoprost ophthalmic solution 0.005%) results in robust and sustained IOP-lowering in ocular normotensive dogs)<\/span><\/p>\n<p><strong>Type<\/strong> : Session de posters<\/p>\n<p><strong>Titre de la session<\/strong> : Aqueous humor Dynamics and IOP<\/p>\n<p><strong>Date<\/strong> : 30 avril 2019 de 8:45 \u00e0 10:30<\/p>\n<p><strong>Pr\u00e9sentation<\/strong> : Michael Bergamini, PhD, Chief Scientific Advisor, Nicox Ophthalmics, Inc.<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>Titre de l&rsquo;abstract<\/strong> : NCX 1741, a novel NO-donating derivative of the phosphodiesterase-5 inhibitor avanafil, reduces IOP in models of ocular hypertension and glaucoma<\/span><\/p>\n<p><strong>Type<\/strong> : Session de posters<\/p>\n<p><strong>Titre de la session<\/strong> : Pharmacologic Interventions and Cellular Mechanisms<\/p>\n<p><strong>Date<\/strong> : 30 avril 2019 de 11:45 \u00e0 13:30<\/p>\n<p><strong>Pr\u00e9sentation<\/strong> : Francesco Impagnatiello, PhD, Institut de recherche de Nicox<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>Titre du poster<\/strong> : Preclinical Evaluation of NCX 4251, a Novel Steroid Therapy for Blepharitis, Targeted Directly to the Eyelid Margin to Reduce the Potential for IOP Elevations<\/span><\/p>\n<p><strong>Type<\/strong> : Session de posters<\/p>\n<p><strong>Titre de la session<\/strong> : Cornea Dry Eye Clinical Treatment<\/p>\n<p><strong>Date<\/strong> : 2 mai 2019 de 10:15 \u00e0 12:00<\/p>\n<p><strong>Pr\u00e9sentation<\/strong> : Tomas Navratil, PhD, Nicox Ophthalmics, Inc.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX, \u00e9ligible PEA-PME), une soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce plusieurs presentations de donn\u00e9es \u00e0 des conf\u00e9rences scientifiques : Informations sur les pr\u00e9sentations (heures locales) : AGS 2019 Annual Meeting \u201314-17 mars 2019, San Francisco, Etats-Unis Titre du poster : Preclinical Evaluation of NCX 4251, A Novel [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[32,16],"tags":[],"class_list":["post-7593","post","type-post","status-publish","format-standard","hentry","category-actualites","category-actualites-et-media"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pr\u00e9sentations Nicox \u00e0 de prochaines conf\u00e9rences scientifiques - Nicox<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.nicox.com\/fr\/presentations-nicox-a-de-prochaines-conferences-scientifiques-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pr\u00e9sentations Nicox \u00e0 de prochaines conf\u00e9rences scientifiques - Nicox\" \/>\n<meta property=\"og:description\" content=\"Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX, \u00e9ligible PEA-PME), une soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce plusieurs presentations de donn\u00e9es \u00e0 des conf\u00e9rences scientifiques : Informations sur les pr\u00e9sentations (heures locales) : AGS 2019 Annual Meeting \u201314-17 mars 2019, San Francisco, Etats-Unis Titre du poster : Preclinical Evaluation of NCX 4251, A Novel [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.nicox.com\/fr\/presentations-nicox-a-de-prochaines-conferences-scientifiques-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Nicox\" \/>\n<meta property=\"article:published_time\" content=\"2019-03-12T07:56:45+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/presentations-nicox-a-de-prochaines-conferences-scientifiques-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/presentations-nicox-a-de-prochaines-conferences-scientifiques-2\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Pr\u00e9sentations Nicox \u00e0 de prochaines conf\u00e9rences scientifiques\",\"datePublished\":\"2019-03-12T07:56:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/presentations-nicox-a-de-prochaines-conferences-scientifiques-2\\\/\"},\"wordCount\":326,\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"articleSection\":[\"Actualit\u00e9s\",\"Actualit\u00e9s et M\u00e9dia\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/presentations-nicox-a-de-prochaines-conferences-scientifiques-2\\\/\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/presentations-nicox-a-de-prochaines-conferences-scientifiques-2\\\/\",\"name\":\"Pr\u00e9sentations Nicox \u00e0 de prochaines conf\u00e9rences scientifiques - Nicox\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\"},\"datePublished\":\"2019-03-12T07:56:45+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.nicox.com\\\/fr\\\/presentations-nicox-a-de-prochaines-conferences-scientifiques-2\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"name\":\"Nicox\",\"description\":\"Visible Science\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\",\"name\":\"Nicox\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Nicox\"},\"image\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pr\u00e9sentations Nicox \u00e0 de prochaines conf\u00e9rences scientifiques - Nicox","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.nicox.com\/fr\/presentations-nicox-a-de-prochaines-conferences-scientifiques-2\/","og_locale":"fr_FR","og_type":"article","og_title":"Pr\u00e9sentations Nicox \u00e0 de prochaines conf\u00e9rences scientifiques - Nicox","og_description":"Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX, \u00e9ligible PEA-PME), une soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce plusieurs presentations de donn\u00e9es \u00e0 des conf\u00e9rences scientifiques : Informations sur les pr\u00e9sentations (heures locales) : AGS 2019 Annual Meeting \u201314-17 mars 2019, San Francisco, Etats-Unis Titre du poster : Preclinical Evaluation of NCX 4251, A Novel [&hellip;]","og_url":"https:\/\/www.nicox.com\/fr\/presentations-nicox-a-de-prochaines-conferences-scientifiques-2\/","og_site_name":"Nicox","article_published_time":"2019-03-12T07:56:45+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.nicox.com\/fr\/presentations-nicox-a-de-prochaines-conferences-scientifiques-2\/#article","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/presentations-nicox-a-de-prochaines-conferences-scientifiques-2\/"},"author":{"name":"","@id":""},"headline":"Pr\u00e9sentations Nicox \u00e0 de prochaines conf\u00e9rences scientifiques","datePublished":"2019-03-12T07:56:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.nicox.com\/fr\/presentations-nicox-a-de-prochaines-conferences-scientifiques-2\/"},"wordCount":326,"publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"articleSection":["Actualit\u00e9s","Actualit\u00e9s et M\u00e9dia"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.nicox.com\/fr\/presentations-nicox-a-de-prochaines-conferences-scientifiques-2\/","url":"https:\/\/www.nicox.com\/fr\/presentations-nicox-a-de-prochaines-conferences-scientifiques-2\/","name":"Pr\u00e9sentations Nicox \u00e0 de prochaines conf\u00e9rences scientifiques - Nicox","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/#website"},"datePublished":"2019-03-12T07:56:45+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.nicox.com\/fr\/presentations-nicox-a-de-prochaines-conferences-scientifiques-2\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.nicox.com\/fr\/#website","url":"https:\/\/www.nicox.com\/fr\/","name":"Nicox","description":"Visible Science","publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.nicox.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.nicox.com\/fr\/#organization","name":"Nicox","url":"https:\/\/www.nicox.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Nicox"},"image":{"@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":""}]}},"_links":{"self":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/7593","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/comments?post=7593"}],"version-history":[{"count":0,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/7593\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/media?parent=7593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/categories?post=7593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/tags?post=7593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}